[难治性哮喘和重度哮喘的诊断方法]。

Q3 Medicine Revista alergia Mexico Pub Date : 2022-01-01 DOI:10.29262/ram.v69iSupl1.1046
Marco Venancio-Hernández, Elizabeth Mendieta-Flores, Jeannette Mendiola-Marín, Angélica Kathya Alaniz-Flores, Mireya Reyes-Arellano
{"title":"[难治性哮喘和重度哮喘的诊断方法]。","authors":"Marco Venancio-Hernández,&nbsp;Elizabeth Mendieta-Flores,&nbsp;Jeannette Mendiola-Marín,&nbsp;Angélica Kathya Alaniz-Flores,&nbsp;Mireya Reyes-Arellano","doi":"10.29262/ram.v69iSupl1.1046","DOIUrl":null,"url":null,"abstract":"<p><p>Difficult-to-treat asthma refers to asthma that is not controlled despite high or medium doses of inhaled steroids or in which high doses of treatment are required to maintain an adequate control of the symptoms and to reduce the risk of exacerbations. An inadequate technique to use the inhaler, poor adherence to treatment, smoking, comorbidities, or an incorrect diagnosis should be considered. In severe asthma, despite adherence to treatment with optimized maximum doses and the management of factors that could contribute, multiple medications in maximum doses are required to have an adequate therapeutic control or this is not achieved. The approach to these patients involves a meticulous process due to the multiple factors that can influence poor asthma control and that can lead to a misclassification of the disease when, in reality, the patient can be presenting different comorbidities whose treatment could decrease the severity of asthma symptoms and modify the prognosis. The objective of this document is to make the approach to patients with difficult-to-treat asthma and severe asthma known, as well as the most frequent comorbidities. A search was made in PubMed with the purpose of identifying the main pathologies that may be present in patients and, based on what is described in the literature, to propose a diagnostic approach. 100 studies were comprised in this review, including clinical guidelines such as GINA, GEMA, and ERS/ATS.</p>","PeriodicalId":21175,"journal":{"name":"Revista alergia Mexico","volume":"69 Suppl 1 ","pages":"s94-s111"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The diagnostic approach to difficult-to-treat asthma and severe asthma].\",\"authors\":\"Marco Venancio-Hernández,&nbsp;Elizabeth Mendieta-Flores,&nbsp;Jeannette Mendiola-Marín,&nbsp;Angélica Kathya Alaniz-Flores,&nbsp;Mireya Reyes-Arellano\",\"doi\":\"10.29262/ram.v69iSupl1.1046\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Difficult-to-treat asthma refers to asthma that is not controlled despite high or medium doses of inhaled steroids or in which high doses of treatment are required to maintain an adequate control of the symptoms and to reduce the risk of exacerbations. An inadequate technique to use the inhaler, poor adherence to treatment, smoking, comorbidities, or an incorrect diagnosis should be considered. In severe asthma, despite adherence to treatment with optimized maximum doses and the management of factors that could contribute, multiple medications in maximum doses are required to have an adequate therapeutic control or this is not achieved. The approach to these patients involves a meticulous process due to the multiple factors that can influence poor asthma control and that can lead to a misclassification of the disease when, in reality, the patient can be presenting different comorbidities whose treatment could decrease the severity of asthma symptoms and modify the prognosis. The objective of this document is to make the approach to patients with difficult-to-treat asthma and severe asthma known, as well as the most frequent comorbidities. A search was made in PubMed with the purpose of identifying the main pathologies that may be present in patients and, based on what is described in the literature, to propose a diagnostic approach. 100 studies were comprised in this review, including clinical guidelines such as GINA, GEMA, and ERS/ATS.</p>\",\"PeriodicalId\":21175,\"journal\":{\"name\":\"Revista alergia Mexico\",\"volume\":\"69 Suppl 1 \",\"pages\":\"s94-s111\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista alergia Mexico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29262/ram.v69iSupl1.1046\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista alergia Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29262/ram.v69iSupl1.1046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

难治性哮喘是指尽管吸入高剂量或中剂量类固醇仍无法控制的哮喘,或需要高剂量治疗以维持对症状的适当控制并减少恶化风险的哮喘。应考虑吸入器使用技术不充分、治疗依从性差、吸烟、合并症或错误诊断。在严重哮喘中,尽管坚持使用最佳最大剂量治疗并对可能起作用的因素进行了管理,但仍需要使用最大剂量的多种药物才能获得充分的治疗控制,否则无法实现。对这些患者的治疗涉及一个细致的过程,因为影响哮喘控制不良的多种因素可能导致疾病的错误分类,而实际上,患者可能出现不同的合并症,其治疗可能会降低哮喘症状的严重程度并改变预后。本文件的目的是使难以治疗的哮喘和严重哮喘患者以及最常见的合并症的方法为人所知。在PubMed上进行了一项搜索,目的是确定患者可能出现的主要病理,并根据文献中描述的内容提出一种诊断方法。本综述纳入了100项研究,包括临床指南,如GINA、GEMA和ERS/ATS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[The diagnostic approach to difficult-to-treat asthma and severe asthma].

Difficult-to-treat asthma refers to asthma that is not controlled despite high or medium doses of inhaled steroids or in which high doses of treatment are required to maintain an adequate control of the symptoms and to reduce the risk of exacerbations. An inadequate technique to use the inhaler, poor adherence to treatment, smoking, comorbidities, or an incorrect diagnosis should be considered. In severe asthma, despite adherence to treatment with optimized maximum doses and the management of factors that could contribute, multiple medications in maximum doses are required to have an adequate therapeutic control or this is not achieved. The approach to these patients involves a meticulous process due to the multiple factors that can influence poor asthma control and that can lead to a misclassification of the disease when, in reality, the patient can be presenting different comorbidities whose treatment could decrease the severity of asthma symptoms and modify the prognosis. The objective of this document is to make the approach to patients with difficult-to-treat asthma and severe asthma known, as well as the most frequent comorbidities. A search was made in PubMed with the purpose of identifying the main pathologies that may be present in patients and, based on what is described in the literature, to propose a diagnostic approach. 100 studies were comprised in this review, including clinical guidelines such as GINA, GEMA, and ERS/ATS.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revista alergia Mexico
Revista alergia Mexico Medicine-Immunology and Allergy
CiteScore
0.70
自引率
0.00%
发文量
9
审稿时长
16 weeks
期刊最新文献
[Kawasaki disease and multisystem inflammatory syndrome in children. Differences, and similarities in a pediatric center in Mexico]. [Adverse drug events in hospitalized patients: prevalence, causes and risk factors]. [Mesenchymal stem cells: Therapeutic option in ARDS, COPD, and COVID-19 patients]. [A drink with an unexpected ending... Adverse reaction by tonic water: A case report]. [Health related to quality life of patients with hereditary angioedema in Argentina. A multicenter study].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1